Company Filing History:
Years Active: 2024
Title: The Innovations of Hongchang Su
Introduction
Hongchang Su is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharma, particularly in the development of chimeric antigen receptors. His work is characterized by a focus on innovative solutions that address critical medical challenges.
Latest Patents
Hongchang Su holds a patent for a "BCMA chimeric antigen receptor based on single domain antibody and use thereof." This innovative chimeric antigen receptor (CAR) includes a BCMA binding domain, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. The BCMA binding domain comprises heavy chain complementarity determining regions HCDR1-3, with the amino acid sequences of the HCDR1-3 being successively represented in SEQ ID NO: 1-3. This patent highlights his expertise in creating targeted therapies for cancer treatment.
Career Highlights
Hongchang Su is currently associated with Shenzhen Pregene Biopharma Co. Ltd., where he continues to push the boundaries of biopharmaceutical research. His work at Pregene has positioned him as a key player in the development of advanced therapeutic solutions.
Collaborations
He collaborates with talented individuals such as Jishuai Zhang and Hongjian Li, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hongchang Su's contributions to the field of biopharma, particularly through his patent on BCMA chimeric antigen receptors, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in targeted therapies.